Company
Headquarters: Indianapolis, IN, United States
Employees: 6,080
CEO: Mr. Daniel J. Starck
$1.33 Billion
USD as of March 1, 2022
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $201.46 B |
| EssilorLuxottica SA | $144.43 B |
| Becton, Dickinson and Company | $55.63 B |
| HOYA Corp | $50.63 B |
| Alcon Inc. | $39.46 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
| Last Financial Reports Date | Dec. 31, 2022 |
| Revenue TTM | €384.5 M |
| EBITDA | €51.8 M |
| Gross Profit TTM | €226.0 M |
| Profit Margin | 1.96% |
| Operating Margin | 2.40% |
| Quarterly Revenue Growth | -16.70% |
Apria, Inc. has the following listings and related stock indices.
Stock: NASDAQ: APR wb_incandescent